Haemonetics reports Q1 FY2022 results; details not available in filing excerpt

HAEMONETICS CORP

2022-Q1 EPS reported -$0.09 revenue$228,528,000

Filed 8-K on Aug 11, 2021 for Q1 ended July 3, 2021 results.
Press release issued but not included in provided text; specific figures unknown.
Event type is earnings; no guidance or segment data presented in filing body.
Confidence low due to missing exhibit details; refer to full filing for numbers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.